α7-Acetylcholine receptor antibodies in two patients with Rasmussen encephalitis

Neurology

Volumn 65, Issue 11, 2005, Pages 1802-1804

  Watson, R ^a   Jepson, J E C ^a   Bermudez, I ^b   Alexander, S ^a   Hart, Y ^c   McKnight, K ^a   Roubertie, A ^d   Fecto, F ^a   Valmier, J ^d   Sattelle, D B ^a   Beeson, D ^a   Vincent, A ^a   Lang, B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD BROOKES UNIVERSITY   (United Kingdom)

^c RADCLIFFE INFIRMARY   (United Kingdom)

^d Montpellier University Medical Center   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BUNGAROTOXIN; ALPHA7 ACETYLCHOLINE RECEPTOR; CHOLINERGIC RECEPTOR; COMPLEMENTARY DNA; IODINE 125; UNCLASSIFIED DRUG; ALPHA-BUNGAROTOXIN RECEPTOR; AUTOANTIBODY; BUNGAROTOXIN; BUNGAROTOXIN RECEPTOR; FLUORESCENT DYE; FURA 2; IMMUNOLOGIC FACTOR; NICOTINIC RECEPTOR;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HUMAN; HUMAN CELL; LIGAND BINDING; PATHOGENESIS; PRIORITY JOURNAL; RASMUSSEN SYNDROME; RECEPTOR BINDING; SERODIAGNOSIS; ANIMAL; BINDING COMPETITION; BLOOD; BRAIN; CALCIUM SIGNALING; DOSE RESPONSE; DRUG EFFECT; ENCEPHALITIS; FEMALE; IMMUNOLOGY; INFANT; INTRACELLULAR FLUID; MALE; METABOLISM; NEUROLOGIC DISEASE; OOCYTE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; RADIOASSAY; XENOPUS LAEVIS;

ADOLESCENT; ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BINDING, COMPETITIVE; BRAIN; BUNGAROTOXINS; CALCIUM SIGNALING; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALITIS; FEMALE; FLUORESCENT DYES; FURA-2; HUMANS; IMMUNOLOGIC FACTORS; INFANT; INTRACELLULAR FLUID; MALE; OOCYTES; RADIOLIGAND ASSAY; RECEPTORS, NICOTINIC; XENOPUS LAEVIS;

EID: 33645061317     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000191566.86977.04     Document Type: Article

References (10)

1. Lang B, Dale RC, Vincent A. New autoantibody mediated disorder of the CNS. Curr Opion Neurol 2003;16:351-357.
2. Bien CG, Widman G, Urbach H, et al. The natural history of Rasmussen's encephalitis. Brain 2002;125:1751-1759.
3. Rogers SW, Andrews PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994;265:648-651.
4. Wiendl H, Bien CG, Bernasconi P, et al. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology 2001;57:511-514.
5. Watson R, Jiang Y, Bermudez I, et al. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen's encephalitis. Neurology 2004;63:43-50.
6. Zhao L, Kuo YP, George AA, et al. Functional properties of homomeric, human α7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line. J Pharmacol Exp Ther 2003;303:1132-1141.
7. Raymond-Delpech V, Towers PR, Sattelle DB. Gene silencing of selected calcium-signalling molecules in a Drosophila cell line using double-stranded RNA interference. Cell Calcium 2004;35:131-139.
8. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-3445.
9. Balestra B, Moretti M, Longhi R, et al. Antibodies against neuronal nicotinic receptor subtypes in neurological disorders. J Neuroimmunol 2000;102:89-97.
10. Gotti C, Fornasari D, Clementi F. Human neuronal nicotinic receptors. Prog Neurobiol 1997;53:199-237.